Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 467

1.

Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population.

Harley C, Li H, Corey-Lisle P, L'Italien GJ, Carson W.

Soc Psychiatry Psychiatr Epidemiol. 2007 Sep;42(9):690-7. Epub 2007 Jun 29.

PMID:
17603740
2.

Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programme.

Qiu Y, Fu AZ, Liu GG, Christensen DB.

Appl Health Econ Health Policy. 2010;8(3):167-77. doi: 10.2165/11318830-000000000-00000.

PMID:
20408601
3.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
4.

Costs associated with attempted suicide among individuals with bipolar disorder.

Stensland MD, Zhu B, Ascher-Svanum H, Ball DE.

J Ment Health Policy Econ. 2010 Jun;13(2):87-92.

PMID:
20919595
5.

Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.

Stensland MD, Jacobson JG, Nyhuis A.

J Affect Disord. 2007 Aug;101(1-3):187-93. Epub 2007 Jan 23.

PMID:
17254637
6.

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.

Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME.

Appl Health Econ Health Policy. 2008;6(2-3):103-12. doi: 10.2165/00148365-200806020-00003.

PMID:
19231904
8.

Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis.

Birnbaum HG, Shi L, Dial E, Oster EF, Greenberg PE, Mallett DA.

J Clin Psychiatry. 2003 Oct;64(10):1201-9.

PMID:
14658969
9.

Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program.

Li J, McCombs JS, Stimmel GL.

J Affect Disord. 2002 Sep;71(1-3):131-9.

PMID:
12167509
11.

Health care utilization and costs among privately insured patients with bipolar I disorder.

Bryant-Comstock L, Stender M, Devercelli G.

Bipolar Disord. 2002 Dec;4(6):398-405.

PMID:
12519100
12.

Medical costs of managed care in patients with type 2 diabetes mellitus.

Bhattacharyya SK, Else BA.

Clin Ther. 1999 Dec;21(12):2131-42.

PMID:
10645758
13.

The impact of treatment-resistant depression on health care utilization and costs.

Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, Russell JM.

J Clin Psychiatry. 2002 Nov;63(11):963-71.

PMID:
12444808
14.

Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.

Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G.

Clin Ther. 2009 Apr;31(4):836-48. doi: 10.1016/j.clinthera.2009.04.022.

PMID:
19446157
15.

Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis.

Stender M, Bryant-Comstock L, Phillips S.

Clin Ther. 2002 Oct;24(10):1668-76.

PMID:
12462295
16.

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.

McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.

J Clin Psychiatry. 2006 Aug;67(8):1187-93.

PMID:
16965195
17.
18.

Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

White RR, Lenhart G, Singhal PK, Insinga RP, Itzler RF, Pellissier JM, Segraves AW.

Pharmacoeconomics. 2009;27(9):781-92. doi: 10.2165/11317560-000000000-00000.

PMID:
19757871
19.

Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents.

Dusetzina SB, Weinberger M, Gaynes BN, Farley JF, Sleath B, Hansen RA.

Pharmacotherapy. 2012 Dec;32(12):1085-94. doi: 10.1002/phar.1148.

PMID:
23208835
20.

Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.

Centorrino F, Mark TL, Talamo A, Oh K, Chang J.

J Clin Psychopharmacol. 2009 Dec;29(6):595-600. doi: 10.1097/JCP.0b013e3181bef8a6.

PMID:
19910727

Supplemental Content

Support Center